The New Order: Integrated Customer Organizations and Cancer Drug Management

Proximity Health’s research service delivers actionable insights through comprehensive primary research

  1. Financial incentives are changing
  • Anthem ties 58% of provider reimbursement to “value”
  • CMS’ Oncology Care Model and MACRA redefine cancer providers’ business models
  1. A set of critical new customers is emerging as oncology care consolidates
  • IDNs owned 60% of oncology practices by late 2015
  • Consolidation continues as changes reward economic scale and negotiating power
  1. ICOs are building structures and processes to guide cancer drug selection
  • ICOs implement restrictive formularies, guidelines, and pathways
  • IT systems knit dispersed oncology networks together
  • Internal Specialty Pharmacy operations leverage 340B pricing

[caldera_form id=”CF592262caca69b”]